COMPANY PROFILE

Mindset Health

Explore full profile

Helps manage chronic health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy

Melbourne, AustraliaFounded 2018Health Tech & Medtech

Valuation $50–100M Last recorded · 2023

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Mindset Health

Mindset Health is a health technology company that develops mobile hypnotherapy programs aimed at helping individuals manage and improve their health without the use of drugs or diets. The company serves clients with medically diagnosed conditions such as irritable bowel syndrome (IBS), menopause, and smoking habits through its apps Nerva, Evia, and Finito. These programs are designed to provide self-management tools that are evidence-backed but are not intended to replace medical advice or treatments prescribed by healthcare providers. Mindset Health operates in the digital health market, focusing on making at-home support accessible to millions of people suffering from chronic health issues. The business model revolves around offering subscription-based access to its hypnotherapy programs, generating revenue through user subscriptions. The company’s mission is to empower a billion people to improve their health by unlocking the power of the mind.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Melbourne, Australia
Employees: 47
Open positions: None listed
Dealroom signal: 77.3/100
Industry: Health
Sub-industry: Health Platform
Sector: Health Tech & Medtech, Spinout, Addiction, YC S19
Technology: Mobile app
Business model: SaaS
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Mar 2023	$12M	$52M	Undisclosed	↗
SEED✓Equity / VC	Jun 2021	$5M	$20M	James Beshara · Banana Capital · Fifty Years · Giant Leap Fund	↗

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Mindset Health website traffic

Latest recorded traffic for Mindset Health is 21K monthly website visits, up 5% over the last three months. Mindset Health's team grew 0% over the past year.

Latest monthly visits21K 3-month web change+5% 1-year team growth0%

Monthly website visitsDec 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ASAchieve Life ScienceA specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic	Bothell, United States	Operational	40	$243M	$604M
OVOVAXFentanyl vaccine technologies to prevent overdoses, focusing on prediction, prevention, and protection	Houston, United States	Operational
ZTZena TherapeuticsInnovative drug discovery targeting alcohol, substance use, and anxiety disorders with a focus on patient safety	Princeton, United States	Operational
RMRebel MedicineBiotech developing safe and effective alternatives to opioids	Salt Lake City, United States	Operational
KTKinoxis TherapeuticsA biotechnology startup developing new therapeutics to address the escalating demand for effective treatments for substance use disorders and social dysfunction in neurological and psychiatric disorders	Melbourne, Australia	Operational
AFAelis FarmaBiotech company conducting research and development on innovative signaling specific drugs	Bordeaux, France	Operational
PPPhoenix PharmaLabsA pre-clinical stage drug development company dedicated to finding improved non-addictive pain treatment	Woods Cross, United States	Operational
EPEpiVarioDeveloping novel compounds to treat memory-related psychiatric disorders at the source of the disease	Philadelphia, United States	Operational